These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. A Fluorescent Peptide Toxin for Selective Visualization of the Voltage-Gated Potassium Channel K Wai DCC; Naseem MU; Mocsár G; Babu Reddiar S; Pan Y; Csoti A; Hajdu P; Nowell C; Nicolazzo JA; Panyi G; Norton RS Bioconjug Chem; 2022 Nov; 33(11):2197-2212. PubMed ID: 36330854 [TBL] [Abstract][Full Text] [Related]
17. Atto488-Agitoxin 2-A Fluorescent Ligand with Increased Selectivity for Kv1.3 Channel Binding Site. Denisova KR; Orlov NA; Yakimov SA; Kirpichnikov MP; Feofanov AV; Nekrasova OV Bioengineering (Basel); 2022 Jul; 9(7):. PubMed ID: 35877346 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate, a small molecular scaffold targeting Kv1.3 channel extracellular pore region. Xie Z; Zhao Y; Yang W; Li W; Wu Y; Chen Z Biochem Biophys Res Commun; 2020 Nov; 532(2):265-270. PubMed ID: 32863001 [TBL] [Abstract][Full Text] [Related]
19. The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker. Yang XF; Yang Y; Lian YT; Wang ZH; Li XW; Cheng LX; Liu JP; Wang YF; Gao X; Liao YH; Wang M; Zeng QT; Liu K PLoS One; 2012; 7(4):e36379. PubMed ID: 22558454 [TBL] [Abstract][Full Text] [Related]
20. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes. Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]